Listed

Nephros Inc: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 14, 2014 and accepted by EDGAR at May 14, 2014, 16:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$473.0kus-gaap:SalesRevenueNet
Cost of revenue3 months2014-01-01 to 2014-03-31$106.0kus-gaap:CostOfGoodsSold
Gross profit3 months2014-01-01 to 2014-03-31$367.0kus-gaap:GrossProfit
Selling, general and administrative3 months2014-01-01 to 2014-03-31$711.0kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-01-01 to 2014-03-31−$562.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31$53.0kus-gaap:InterestExpense
Net income3 months2014-01-01 to 2014-03-31−$760.0kus-gaap:NetIncomeLoss
Operating cash flow3 months2014-01-01 to 2014-03-31−$622.0kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-03-31$473.0kus-gaap:Cash
Current assetsAt period end2014-03-31$1.2mus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$3.1mus-gaap:Assets
Current liabilitiesAt period end2014-03-31$2.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-03-31$2.3mus-gaap:Liabilities
Shareholders' equityAt period end2014-03-31$766.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-030411. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.